Intuitive Surgical Stock Remains Suppressed, Despite Procedure Growth

Anti-corruption campaigns in China, a shift towards leasing systems and the ever-problematic presence of GLP-1 inhibitors has led analysts, journalists and commentators to voice concerns about the robotic surgery giant.